海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业 务。医院业务分部从事提供肿瘤一站式综合诊疗服务，围绕肿瘤核心业务开展多学科医疗服务，包括提 供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务，逐步覆盖癌症诊断、治疗与康复等各阶段。 其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。 证券之星消息，2月27日南向资金减持44.58万股海吉亚医疗（06078.HK）。近5个交易日中，获南向资 金减持的有3天，累计净减持64.54万股。近20个交易日中，获南向资金减持的有11天，累计净减持 385.88万股。截至目前，南向资金持有海吉亚医疗（06078.HK）2.0亿股，占公司已发行普通股的 32.3%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业 务。医院业务分部从事提供肿瘤一站式综合诊疗服务，围绕肿瘤核心业务开展多学科医疗服务，包括提 供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务，逐步覆盖癌症诊断、治疗与康复等各阶段。 其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月26日南向资金减持64.52万股海吉亚医疗（06078.HK）。近5个交易日中，获南向资 金减持的有3天，累计净减持278.7万股。近20个交易日中，获南向资金减持的有11天，累计净减持367.9 万股。截至目前，南向资金持有海吉亚医疗（06078.HK）2.0亿股，占公司已发行普通股的32.38%。 ...

海吉亚医疗(06078)公布，2026年2月25日耗资约499.9万港元回购35.88万股股份。 ...

格隆汇2月25日丨海吉亚医疗(06078.HK)发布公告，2026年2月25日耗资499.9万港元回购35.88万股，回 购价格每股13.84-14.02港元。 ...

智通财经APP讯，海吉亚医疗(06078)公布，2026年2月25日耗资约499.9万港元回购35.88万股股份。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 海吉亞醫療控股有限公司 呈交日期： 2026年2月25日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06078 | 說明 | 普通股 | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（ ...

海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业 务。医院业务分部从事提供肿瘤一站式综合诊疗服务，围绕肿瘤核心业务开展多学科医疗服务，包括提 供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务，逐步覆盖癌症诊断、治疗与康复等各阶段。 其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。 证券之星消息，2月23日南向资金增持70.0万股海吉亚医疗（06078.HK）。近5个交易日中，获南向资金 减持的有3天，累计净减持226.46万股。近20个交易日中，获南向资金减持的有11天，累计净减持345.14 万股。截至目前，南向资金持有海吉亚医疗（06078.HK）2.01亿股，占公司已发行普通股的32.48%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Core Viewpoint - Southbound funds have reduced their holdings in Hai Ji Ya Medical (06078.HK) by 416,400 shares on February 13, with a total net reduction of 2,295,000 shares over the past five trading days and 5,217,400 shares over the last twenty trading days [1] Group 1: Southbound Fund Activity - Southbound funds have reduced their holdings in Hai Ji Ya Medical for three out of the last five trading days, totaling a net reduction of 2,295,000 shares [1] - Over the past twenty trading days, there have been twelve days of reductions, with a cumulative net decrease of 5,217,400 shares [1] - As of now, southbound funds hold 200 million shares of Hai Ji Ya Medical, representing 32.34% of the company's total issued ordinary shares [1] Group 2: Company Overview - Hai Ji Ya Medical Holdings Limited is primarily an investment holding company that provides medical services [1] - The company operates through two business segments, with the hospital business segment focusing on comprehensive cancer diagnosis and treatment services [1] - The other business segment is involved in various other operations, primarily within the domestic market [1]

Core Viewpoint - Southbound funds have reduced their holdings in Hai Ji Ya Medical (06078.HK) by 2.5874 million shares on February 12, indicating a trend of net selling over recent trading days [1] Summary by Category Southbound Fund Activity - In the last 5 trading days, there were 2 days of net selling by southbound funds, totaling a reduction of 1.857 million shares [1] - Over the past 20 trading days, there were 12 days of net selling, with a cumulative reduction of 5.818 million shares [1] - Currently, southbound funds hold 201 million shares of Hai Ji Ya Medical, which represents 32.41% of the company's total issued ordinary shares [1] Company Overview - Hai Ji Ya Medical Holdings Limited is primarily an investment holding company that provides medical services [1] - The company operates through two business segments: the hospital business segment focuses on comprehensive diagnosis and treatment services for cancer, offering multidisciplinary medical services including radiotherapy, chemotherapy, surgery, and targeted therapy [1] - The other business segment is involved in various other operations, with the company primarily conducting its business in the domestic market [1]

Group 1 - The company, Haijia Medical (06078.HK), announced a share buyback of 140,000 shares at a total cost of HKD 1.9939 million, with a buyback price range of HKD 14.22 to 14.27 per share [1] - As of the market close on February 12, 2026, Haijia Medical's stock price was HKD 14.27, reflecting a decline of 1.11%, with a trading volume of 2.1016 million shares and a total transaction value of HKD 30.0401 million [1] - The stock is primarily rated as "Hold" by investment banks, with one bank providing a "Hold" rating in the last 90 days and a target price of HKD 13.5 [1] Group 2 - Haijia Medical has a market capitalization of HKD 8.898 billion and ranks 6th in the medical services sector [2]